Add Row 
Add 
⚠️ Xanax XR 3 mg Recall: What You Need to Know
A nationwide recall has been issued for a specific batch of Xanax XR 3 mg tablets. Here's a straightforward breakdown of what's happening and what to do if you're affected.
What's Being Recalled
The recall covers Xanax XR 3 mg extended-release tablets, packaged in 60-tablet bottles and distributed by Viatris Specialty LLC. If you received this medication between August 27, 2024 and May 29, 2025, check your bottle for the following:
Lot number: 8177156
Expiration date: 02/28/2027
If both match, your medication is part of this recall.
Why Are These Pills Being Recalled?
The affected tablets failed dissolution testing, meaning they may not break down or absorb correctly in your body — which could make them less effective than intended.
The FDA has classified this as a Class II recall, the middle tier of its three-level system. This means the risk of serious or permanent harm is considered low, but mild or temporary health effects are possible.
What Should You Do?
Stop taking the medication immediately if your pills match the lot number and expiration date above. Then:
Contact your pharmacy — they should be aware of the recall and can advise on a replacement.
Reach out to your prescribing doctor to discuss next steps and ensure you have an uninterrupted supply of your medication.
Do not simply stop taking alprazolam (Xanax) without medical guidance — abrupt discontinuation can cause withdrawal symptoms.
Current Status
As of now, no adverse reactions have been reported in connection with this recall. Viatris has not yet released a public statement, and the FDA has been contacted for further comment.
Why This Matters
An estimated 3.6 million Americans fill Xanax prescriptions each year, making broad awareness of this recall especially important. If you or someone you know takes this medication, it's worth double-checking that bottle.
Check the FDA's recall database at FDA.gov for the latest updates on this recall.
Write A Comment